Case Summary:            

Improving early diagnostic accuracy isn’t just a technical goal—it’s a public health imperative. For one physician from Jordan, this mission has been the heart of his work in internal medicine. Focused on reducing diagnostic errors and enhancing care in pulmonary and critical care settings, this physician’s contributions were recently recognized through the approval of his EB-2 National Interest Waiver (NIW) petition, supported by NAILG and processed under premium review.

Despite receiving a Request for Evidence (RFE) shortly after filing, our legal team presented a compelling case that underscored the national merit of his clinical and academic research. The petition was approved on June 26, 2025, affirming the client’s significant impact on U.S. healthcare priorities.

Research That Tackles a Critical Healthcare Gap

At the center of this physician’s endeavor is a focus on patient-level data analysis to identify diagnostic gaps and propose novel therapeutic strategies for patients with pulmonary diseases and those in critical care. His work involves studying diagnostic delays in conditions like pulmonary embolism and lung cancer, and developing tools to reduce medical errors in intensive care units.

One of his key objectives is to build enhanced early-stage diagnostic modalities that can be applied directly in both inpatient and outpatient care. These innovations are designed to lower the incidence of misdiagnosis—a pressing issue in the United States, where diagnostic errors impact thousands annually.

Credentials That Underscore National Value

At the time of filing, the client had built a strong academic profile:

• 9 peer-reviewed journal articles, with 5 as first author
• 19 scientific abstracts, including 10 first-authored submissions
• 36 citations and references from other researchers leveraging his work in gastric lipomas, endocarditis, and critical care unit models
• Research published in American Journal of Respiratory and Critical Care Medicine, one of the most highly ranked journals in pulmonology
• Clinical work in both pulmonary and general internal medicine settings, including contributions to clinical trials in critical care

His paper on tricuspid valve endocarditis and another on gastric lipoma treatment have both been cited in later studies, affirming the real-world application and ongoing relevance of his findings.

Legal Strategy and Outcome

Despite receiving an RFE in February 2025, the case was strengthened with updated documentation highlighting the influence of his research and a strategic focus on how his work aligns with U.S. public health goals. By emphasizing his contribution to reducing diagnostic errors, enhancing treatment pathways, and participating in cutting-edge clinical trials, NAILG demonstrated that waiving the labor certification would clearly benefit the United States.

His petition was filed on January 13, 2025, and was approved by June 26, 2025, following a detailed and successful response to USCIS.

This case reflects how a deep understanding of critical care and diagnostic science can translate into impactful change within the U.S. healthcare system. We are proud to support this physician’s journey and celebrate his EB-2 NIW approval as a win not just for him, but for patients and providers across the country.